Mode
Text Size
Log in / Sign up

Case report and review highlights ultrasound-guided microwave ablation for metastatic breast cancer in a single patient

Case report and review highlights ultrasound-guided microwave ablation for metastatic breast…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider ultrasound-guided microwave ablation as a minimally invasive option for metastatic breast cancer based on a single case.

This publication is a case report and review of the literature focusing on ultrasound-guided microwave ablation for metastatic breast cancer. The scope includes a single 59-year-old female with a history of lung adenocarcinoma and a solitary breast metastatic lesion. The intervention involved ultrasound-guided microwave ablation, and the comparator was not reported. The primary outcome assessed was sustained local tumor control without recurrence or major complications.

The main results indicate that the patient maintained sustained local tumor control. There was no recurrence observed during the 36-month follow-up period. Additionally, no major complications were reported during this time. The study does not provide absolute numbers for adverse events or statistical measures such as p-values or confidence intervals because the sample size was one case.

The authors note that the evidence is limited to a single case and a review of the literature. Consequently, the findings cannot be generalized to a broader population. The practice relevance is highlighting microwave ablation as a viable minimally invasive therapeutic option for metastatic breast cancer patients. Further research is needed to confirm these findings in larger cohorts.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
This case describes the application of ultrasound-guided microwave ablation (MWA) in the management of a solitary breast metastatic lesion in a 59-year-old female with a history of lung adenocarcinoma. Over a 36-month follow-up period, imaging and clinical assessments demonstrated sustained local tumor control without recurrence or major complications, highlighting MWA as a viable minimally invasive therapeutic option for metastatic breast cancer patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.